Get a Rybelsus® prescription online
Rybelsus® is a GLP-1 you can take by mouth once daily, helping you manage both weight and blood sugar.
- Lose up to 5% of your body weight
- First GLP-1 you can take by mouth once a day
- Supports blood sugar control
Book a visit to see if Rybelsus can help you reach your weight loss goals
Access to medications require a consultation with a licensed clinician via QuickMD. If eligible, the clinician will recommend the best option for you.
Book a consultation for Rybelsus
Safe and affordable medical weight loss treatment. No insurance required.
Getting started with Rybelsus at QuickMD
Description
Rybelsus (semaglutide) is an FDA-approved prescription medication for type 2 diabetes that is also used to support weight management. It works by mimicking a natural hormone in your body called GLP-1, which helps regulate appetite, slow digestion, and improve how your body handles blood sugar. Taken daily in a tablet form, it offers a non-injection option within the GLP-1 class of medications. If you're considering medication to support your weight loss journey, you can meet with a QuickMD doctor today and explore if Rybelsus is the right fit for you.
-
Take Rybelsus by mouth once daily in the morning, or as directed by your QuickMD provider. Swallow it whole with up to 4 ounces of plain water on an empty stomach, and wait at least 30 minutes before eating, drinking, or taking other medications. Typical dose starts with 3 mg once daily for 30 days to acclimate, then increase to 7 mg. A 14 mg dose may be prescribed for further glycemic control.
-
- Lose up to 5% body weight
- Reduces appetite and cravings
- Slows digestion to help you feel fuller longer
- Oral option for those who prefer not to use injections
- Improves blood sugar control
-
Rybelsus ingredients include: semaglutide (active ingredient), magnesium stearate, microcrystalline cellulose, povidone, and salcaprozate sodium.
-
- Nausea
- Diarrhea
- Decreased appetite
- Indigestion or abdominal pain
-
Rybelsus must be prescribed by a licensed provider for use. Like any medication, Rybelsus comes with important safety considerations, including possible side effects, serious risks, and certain conditions where it may not be safe to use. Patients should not use if they or their family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Learn more about Rybelsus safety information.
Weight loss consultation
Personalized consultation with a licensed doctor who can assess your individual needs and prescribe a GLP-1 medication, if appropriate.
- Includes visit with doctor to discuss GLP-1s
- Access to prescription weight loss medication, if approved
- No insurance needed, no membership, and no surprise fees
Not available in LA.
Frequently asked questions
The Rybelsus manufacturer’s current list price is $997.98 for each package. However, most people don’t pay the list price. If you have insurance, NovoCare has a savings offer where you could pay as little as $10 for a 1-month, 2-month, or 3-month prescription. Eligible patients may have access to Rybelsus at no cost through the Patient Assistance Program. For up-to-date pricing, learn more at NovoCare.
Rybelsus (semaglutide) is FDA-approved to treat type 2 diabetes, but some providers also prescribe it off label to support weight loss. “Off label” simply means the FDA hasn’t officially approved the medication for weight management, but it doesn’t mean it’s unsafe or uncommon. In clinical trials, people taking oral semaglutide lost weight, and higher doses studied have shown losses of up to 15% of body weight when paired with healthy habits like balanced eating and regular activity. There’s also another form of semaglutide that is FDA-approved for weight management, called Wegovy, which is given as a weekly injection. Both medications use the same active ingredient and work in a similar way.
In clinical studies, adults taking the currently FDA-approved doses of Rybelsus for type 2 diabetes (3 mg, 7 mg, and 14 mg daily) lost an average of about 3–5% of their body weight. In research trials of higher oral doses of semaglutide, participants lost up to 15% of their body weight when paired with healthy lifestyle changes. Everyone’s results are different, but Rybelsus may support steady weight loss along with better blood sugar control.
How to get Rybelsus online
Book a visit with a QuickMD doctor to discuss Rybelsus
Getting started is simple. Book a convenient online visit with a QuickMD doctor from the comfort of your home, any day of the week, with same-day visits available. During your visit, you'll have the chance to ask questions, share your health history, and learn whether Rybelsus could be a good fit for you. It's a safe, confidential environment to explore your options and take the first step toward your weight loss goals. From your very first visit, you'll have a doctor who listens and helps you feel confident in your next steps.
Discuss your weight loss goals and needs with a doctor
Your doctor will take the time to understand your personal goals, challenges, and lifestyle. Together, you'll review your options and create a plan that feels realistic and supportive. This is your opportunity to talk openly about what you hope to achieve and what kind of care will help you feel most successful. You'll also learn what to expect in terms of timelines, potential side effects, and how progress is monitored. Your doctor will meet you where you are and help set weight loss goals that feel achievable.
Pick up your Rybelsus prescription, if prescribed
If your doctor determines Rybelsus is right for you, they'll send a prescription to your local or preferred pharmacy. From there, you can pick it up at a time that works for you and begin your treatment plan. You'll get clear instructions about dosage, how to use it, and what follow-ups will look like. From the first dose to your follow-ups, you'll have the support you need to feel confident in your weight loss plan. Our goal is to make sure you feel cared for and supported throughout your weight loss journey.